Cassava Sciences, Inc. (SAVA)

2.16 +0.03 (+1.41%) USD  |  NASDAQ  |  Feb 23, 16:00
2.15 -0.01 (-0.46%) After-Hours: 16:49
More

Cassava Sciences Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for SAVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
cbdMD, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Ovid Therapeutics, Inc. Upgrade